- First Chinese Vaccine Manufacturer to Receive Mexican GMP Certificate -
Press Release Source: Sinovac Biotech Ltd. On Thursday August 11, 2011, 8:00 am EDT
BEIJING, Aug. 11, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today that it has obtained the GMP certificate for its seasonal flu vaccine and hepatitis A vaccine from the Mexican regulatory authority, the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) of Mexico Ministry of Health. Sinovac is the first Chinese vaccine manufacturer to be granted GMP certificate by COFEPRIS. The GMP certification follows the onsite inspection by COFEPRIS at Sinovac's Beijing headquarters in September 2010. The GMP certificate is effective for 30 months with an expiration date of January 12, 2014, at which time a new GMP inspection shall be applied for the renewal of GMP certificate. Laboratorios Imperiales S.A. de C.V., a biopharmaceutical company with operations in Mexico since 1935, is the exclusive distributor of Sinovac's vaccine products in the Mexican market, pursuant to a prior distribution agreement signed in 2005 with its affiliate.
Mr. Weidong Yin, Chairman, President and CEO, stated, "We are very excited to receive the Mexican GMP certificate, which is a significant milestone as we advance our global commercialization strategy to register our vaccines. In terms of next steps, we plan to submit the additional documentations for our seasonal flu vaccine Anflu, required by COFEPRIS in order to complete the registration process. We anticipate that the Certificate of Approval for Anflu will be granted in the coming months in order to commercially launch the vaccine in Mexico. The Mexican market is regarded by Sinovac as another significant market for Anflu and Healive, outside of China. We look forward to participating in the government tender process as well as private market sales, in collaboration with our partner in Mexico."
Yin continued, "We plan to initiate the registration process for our inactivated hepatitis A vaccine Healive in Mexico after the Certificate of Approval is granted for Anflu."
The Certificate of Approval for PANFLU.1, Sinovac's H1N1 pandemic influenza (swine flu) vaccine, was granted by the Secretaria de Salud, Mexico Ministry of Health, in 2009.
Recent SVA News
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/12/2024 08:03:46 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/16/2024 08:15:10 PM
- SINOVAC Reports Unaudited First Half of 2024 Financial Results • Business Wire • 08/16/2024 12:54:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/17/2024 08:02:44 PM
- SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F • Business Wire • 04/29/2024 09:53:00 PM
- Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] • Edgar (US Regulatory) • 02/21/2024 11:09:13 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/21/2024 11:02:10 AM
- Sinovac Amends Shareholder Rights Plan • Business Wire • 02/21/2024 07:56:00 AM
- Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 02/02/2024 04:19:55 PM
- シノバック取締役会、一方的な部分公開買い付けを全会一致で退ける • Business Wire • 01/19/2024 11:58:00 AM
- Sinovac董事會一致反對Alternative Liquidity主動提出的部分公開收購方案 • Business Wire • 01/18/2024 07:54:00 PM
- Le conseil d'administration de Sinovac rejette à l'unanimité une offre partielle non sollicitée • Business Wire • 01/18/2024 07:47:00 PM
- Das Board of Directors von Sinovac lehnt einstimmig ein unaufgefordert abgegebenes Teilkaufangebot ab • Business Wire • 01/18/2024 06:33:00 PM
- Form SC 14D9 - Solicitation, recommendation statements • Edgar (US Regulatory) • 01/18/2024 12:13:31 PM
- Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer • Business Wire • 01/18/2024 12:00:00 PM
- Form SC TO-T - Tender offer statement by Third Party • Edgar (US Regulatory) • 01/08/2024 09:46:34 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/04/2023 11:01:59 AM
- Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 10/03/2023 01:39:57 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM